IRIS
BRACCI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.416
EU - Europa 13.232
AS - Asia 6.421
SA - Sud America 1.094
AF - Africa 355
Continente sconosciuto - Info sul continente non disponibili 334
OC - Oceania 29
Totale 37.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.189
GB - Regno Unito 2.821
CN - Cina 2.393
RU - Federazione Russa 2.389
IT - Italia 2.274
SG - Singapore 1.843
IE - Irlanda 1.502
SE - Svezia 988
BR - Brasile 889
UA - Ucraina 883
DE - Germania 827
FR - Francia 642
VN - Vietnam 603
HK - Hong Kong 471
KR - Corea 343
FI - Finlandia 327
ZA - Sudafrica 196
IN - India 183
ES - Italia 156
BD - Bangladesh 128
CA - Canada 122
PL - Polonia 90
BE - Belgio 76
NL - Olanda 70
AR - Argentina 69
JP - Giappone 62
TR - Turchia 57
PK - Pakistan 52
MX - Messico 51
NG - Nigeria 45
IQ - Iraq 39
CZ - Repubblica Ceca 34
EC - Ecuador 34
IR - Iran 28
AT - Austria 26
VE - Venezuela 26
CI - Costa d'Avorio 25
AU - Australia 23
ID - Indonesia 23
PH - Filippine 23
CL - Cile 19
KE - Kenya 19
CH - Svizzera 18
MA - Marocco 18
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 16
CO - Colombia 16
EG - Egitto 16
RO - Romania 16
IL - Israele 15
LT - Lituania 15
SA - Arabia Saudita 15
AZ - Azerbaigian 14
JO - Giordania 13
PE - Perù 13
EU - Europa 12
PY - Paraguay 12
KZ - Kazakistan 11
TN - Tunisia 11
DZ - Algeria 10
JM - Giamaica 10
NP - Nepal 10
RS - Serbia 9
EE - Estonia 8
KG - Kirghizistan 8
BG - Bulgaria 7
BO - Bolivia 7
BY - Bielorussia 7
CR - Costa Rica 7
DK - Danimarca 7
LB - Libano 7
AL - Albania 6
BB - Barbados 6
ET - Etiopia 6
MY - Malesia 6
PA - Panama 6
HU - Ungheria 5
NZ - Nuova Zelanda 5
OM - Oman 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
CY - Cipro 3
GD - Grenada 3
GE - Georgia 3
GY - Guiana 3
HR - Croazia 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
Totale 37.526
Salva come PNG Salva come JPEG
Città #
Southend 2.475
Dallas 1.815
Dublin 1.484
Fairfield 1.460
Ashburn 1.253
Singapore 1.010
Chandler 871
Menlo Park 828
Woodbridge 722
Jacksonville 717
Moscow 675
Santa Clara 665
Houston 582
San Jose 570
Beijing 566
Seattle 557
Wilmington 530
Milan 509
Siena 500
Ann Arbor 493
Cambridge 455
Hong Kong 448
Hefei 413
Council Bluffs 374
Seoul 340
Princeton 272
Los Angeles 234
New York 233
The Dalles 229
Nanjing 218
Rome 207
Johannesburg 182
Ho Chi Minh City 157
Munich 146
Helsinki 138
Lauterbourg 138
Boardman 129
Hanoi 125
Málaga 112
Shanghai 109
San Mateo 108
Florence 104
Buffalo 100
Dong Ket 91
Nanchang 89
São Paulo 88
San Diego 84
Columbus 74
Fremont 61
London 61
Hebei 59
Warsaw 58
Brussels 57
Shenyang 57
Chicago 54
Dearborn 53
Orem 51
Tianjin 49
Washington 49
Abuja 45
Brooklyn 45
Bengaluru 44
Frankfurt am Main 44
Toronto 43
Turku 43
Tokyo 41
Redwood City 40
Kunming 39
Jiaxing 38
Chennai 37
Figino 36
Phoenix 35
Jinan 33
Montreal 32
Changsha 31
Redondo Beach 31
Stockholm 30
Turin 30
Düsseldorf 29
Izmir 29
Amsterdam 27
Da Nang 27
Denver 26
San Francisco 26
Abidjan 25
Atlanta 25
Lancaster 25
Rio de Janeiro 25
University Park 25
Haiphong 24
Zhengzhou 24
Brno 23
Dhaka 23
Manchester 23
Boston 22
Brasília 22
Hangzhou 22
Bagno a Ripoli 21
Belo Horizonte 21
Lappeenranta 21
Totale 25.540
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 388
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 379
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 375
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 373
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 372
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 370
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 369
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment 363
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 359
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 348
11β-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts 338
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 337
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 333
A model of the rabies virus glycoprotein active site 324
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist 321
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 321
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 319
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 318
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 317
A new NT4 peptide-based drug delivery system for cancer treatment 314
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 313
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 312
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 311
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 307
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 305
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 304
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 302
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 299
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 298
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 295
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 288
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 285
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 284
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 283
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 282
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 281
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 277
HIV-1 gp 120 binding to nicotinig receptors 276
Tumor imaging with tetrabranched neurotensin 273
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 273
Branched peptides as bioactive molecules for drug design 273
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 271
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 271
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 267
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 263
An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes 262
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 262
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 260
Antibacterial peptides and analogues thereof 260
Branched Neurotensin For Tumor Targeting 259
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 257
Bioactive peptides from libraries 255
Toxin-related antibodies with antimicrobial and antiviral activity 254
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 252
Branched peptides for tumor diagnosis and therapy 251
Nanoparticles exposing neurotensin tumor-specific drivers 250
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 249
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 249
HIV-1 and human myelin proteins share an antigenic determinant 246
Branched peptides as targeting agents for tumor imaging and therapy 245
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 243
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 242
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 240
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 239
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 239
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 238
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 237
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 237
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 233
Endogenous morphine modulates acute thermonociception in mice 233
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 233
Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein 232
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 232
Branched Neurotensin peptides for tumor personalized therapy 231
Branched peptides as therapeutics 230
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 230
Branched multimeric peptides for tumor diagnosis and therapy 228
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 227
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 226
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 226
Synthetic peptides in the form of dendrimers become resistant to protease activity 224
Identification of a neutralizing epitope on tosv gn glycoprotein 223
The development of antimicrobial peptides as new antibacterial drugs 221
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 217
The antimicrobial peptide M33. An example of drug development 217
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate 216
Branched neurotensin for tumor targeting 216
Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Is the nicotinic acetylcholine receptor an HIV receptor? 215
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 215
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 214
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 214
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 212
Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera 212
Tumor selective targeting by branched peptides 210
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 209
Binding of HIV-1 gp120 to the nicotinic receptor 209
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 209
Molecular basis of branched peptides resistance to enzyme proteolysis 207
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 206
Synthetic peptides of rubella E1 glycoprotein for serological assays 204
Totale 26.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.089 0 266 151 228 134 83 109 109 97 246 203 463
2022/20233.154 186 320 407 441 337 601 62 252 241 141 122 44
2023/20242.360 80 76 232 115 100 681 817 50 9 42 17 141
2024/20254.693 96 225 525 268 567 262 169 302 367 170 531 1.211
2025/202611.842 857 1.592 1.512 1.411 2.281 446 1.125 393 428 580 283 934
2026/2027757 498 259 0 0 0 0 0 0 0 0 0 0
Totale 37.881